Kite Earns Patent for Method to Increase Efficacy of CAR-T Genetic Engineering & Biotechnology NewsFull coverage https://www.genengnews.com/gen-exclusives/kite-earns-patent-for-method-to-increase-efficacy-of-car-t/77901032
FDA signs off on Atara’s IND for MS candidate ATA188 Investing.comFull coverage https://www.investing.com/news/stock-market-news/fda-signs-off-on-ataras-ind-for-ms-candidate-ata188-1086581
HemaCare Announces OneBlood Exercises Second Investment Tranche Option Digital JournalFull coverage http://www.digitaljournal.com/pr/3614428
MedMen Launches ‘Faces’ Cannabis Ad Campaign in California GanjapreneurFull coverage https://www.ganjapreneur.com/medmen-launches-faces-cannabis-ad-campaign-in-california/
Atara Starts Two Phase 3 Trials of Treatment for Lymphoma That Arises from a Transplant Lymphoma News TodayFull coverage https://lymphomanewstoday.com/2018/01/04/atara-to-test-lymphoma-treatment-for-transplant-recipients-in-two-phase-3-trials/
MedMen One of First Marijuana Shops Open in WeHo NBC Southern CaliforniaFull coverage https://www.nbclosangeles.com/on-air/as-seen-on/MedMen-One-of-First-Marijuana-Shops-Open-in-WeHo_Los-Angeles-467674053.html
Atara Biotherapeutics Shares Rise on FDA Approval San Fernando Valley Business JournalAtara Biotherapeutics Gets FDA Approval and Stock Climbs Over 20% MicroSmallCap (press release)Full coverage http://sfvbj.com/news/2017/dec/29/atara-biopharmaceutics-shares-rise-fda-approval/
Emmaus Life Sciences Sickle Cell Treatment Receives Positive Opinion on Pediatric Investigation Plan from European … Business Wire (press release)Full coverage https://www.businesswire.com/news/home/20171221006139/en/Emmaus-Life-Sciences-Sickle-Cell-Treatment-Receives
FDA Approves First Gene Therapy for Genetic Disease Genetic Engineering & Biotechnology NewsSpark plug: Luxturna green-lighted to treat rare RPE65-associated vision loss BioWorld OnlineFull coverage https://www.genengnews.com/gen-news-highlights/fda-approves-first-gene-therapy-for-genetic-disease/81255291